MethodAdded (g mL-1 )5-HT2 Receptor Modulator site BCGBTB5.0 ten 15 5.0 10Recovery 99.ten

MethodAdded (g mL-1 )5-HT2 Receptor Modulator site BCGBTB5.0 ten 15 5.0 10Recovery 99.ten 100.20 99.40 99.30 99.50 one ROCK2 Accession hundred.Precision RSD a 0.42 0.78 1.16 0.53 0.90 1.Intraday Accuracy RE
MethodAdded (g mL-1 )BCGBTB5.0 ten 15 5.0 10Recovery 99.10 one hundred.20 99.40 99.30 99.50 100.Precision RSD a 0.42 0.78 1.16 0.53 0.90 1.Intraday Accuracy RE -0.90 0.20 -0.60 -0.70 -0.50 0.50 Self-assurance limitb 4.955 0.021 ten.02 0.078 14.91 0.173 4.965 0.026 9.95 0.09 20.10 0.231 Recovery 99.60 99.80 99.20 100.60 99.40 99.Precision RSD a 0.51 0.75 1.02 0.40 0.68 0.Interday Accuracy RE -0.40 0.20 -0.80 0.60 -0.60 -0.Self-assurance limitb 4.98 0.025 9.98 0.075 14.88 0.152 5.03 0.020 9.94 0.068 19.92 0.abMean of six determinations; RSD : percentage relative regular deviation; RE : percentage relative error. Confidence limit at 95 self-assurance level and 5 degrees of freedom ( = two.571).Journal of Analytical Solutions in ChemistryJournal of Analytical Methods in ChemistryTable 5: Determination of GMF in its pharmaceutical dosage types applying the common addition method.Reagent Taken (g mL-1 ) Pure drug added (g mL-1 )two.BCG2.BCP2.BPB2.BTB5.MO4.0 eight.0 12 two.0 six.0 ten four.0 8.0 12 four.0 8.0 12 5.0 10Factive tablets Flobiotic tablet GemiQue tablets Total located (g mL-1 ) Recovery a SD Total located (g mL-1 ) Recovery SD Total found (g mL-1 ) Recovery SD five.96 99.30 0.78 five.98 99.60 0.67 6.02 100.30 0.51 9.91 99.ten 1.02 ten.02 100.20 0.82 9.92 99.20 0.70 13.97 99.80 1.24 13.96 99.70 1.09 13.99 99.90 0.94 3.996 99.90 0.66 3.96 99.10 0.42 3.97 99.30 0.38 eight.02 100.20 0.90 7.98 99.80 0.69 7.99 99.90 0.84 11.92 99.30 0.95 12.05 one hundred.40 1.03 11.95 99.60 1.17 5.97 99.50 0.57 five.99 99.80 0.36 6.01 one hundred.15 0.76 9.97 99.70 0.76 9.96 99.60 0.49 9.97 99.70 0.96 13.87 99.ten 1.14 13.97 99.90 0.78 13.89 99.20 1.21 six.03 100.50 0.48 six.01 100.ten 0.53 6.01 100.10 0.54 9.90 99.00 0.72 9.96 99.60 0.85 9.96 99.60 1.03 13.93 99.50 0.97 13.96 99.70 1.31 14.04 100.30 1.15 9.97 99.70 0.32 9.91 99.ten 0.70 9.99 99.90 0.65 14.94 99.60 0.56 15.06 100.40 1.05 14.97 99.80 0.85 24.95 99.80 0.90 24.88 99.50 1.25 24.90 99.60 1.aAverage of six determinations.Table 6: Determination of MXF in its pharmaceutical dosage forms applying the normal addition strategy.Reagent Taken (g mL-1 ) Pure drug added (g mL-1 )two.BCP2.BPB2.BTB5.MO2.0 6.0 10 4.0 8.0 12 two.0 four.0 8.0 5.0 10Avelox tablets Moxiflox tablets Moxifloxacin tablets Total located (g mL-1 ) Recovery a SD Total located (g mL-1 ) Recovery SD Total located (g mL-1 ) Recovery SD 3.98 99.40 0.56 three.96 99.ten 0.62 3.98 99.60 0.48 7.98 99.70 0.83 8.06 one hundred.70 0.89 7.98 99.80 1.ten 11.89 99.10 1.20 12.02 one hundred.20 1.26 11.92 99.30 1.17 5.98 99.60 0.61 five.97 99.50 0.35 5.96 99.30 0.36 9.99 99.90 0.84 9.96 99.60 0.60 9.99 99.90 0.63 14.07 one hundred.50 1.14 13.99 99.90 0.85 14.08 100.60 1.36 3.98 99.50 0.48 3.97 99.20 0.33 four.01 100.20 0.61 5.95 99.20 0.92 five.99 99.80 0.65 5.96 99.30 0.84 10.04 100.40 1.17 10.01 one hundred.ten 0.93 9.95 99.50 1.07 9.91 99.10 0.42 9.94 99.40 0.37 9.95 99.50 0.45 15.08 100.50 0.76 15.03 one hundred.20 0.75 14.97 99.80 0.85 19.90 99.50 1.16 19.92 99.60 1.28 19.83 99.15 0.Journal of Analytical Techniques in ChemistryaAverage of six determinations.Journal of Analytical Approaches in ChemistryTable 7: Determination of ENF in its pharmaceutical dosage forms applying the common addition technique. ReagentTaken (g mL-1 ) Pure drug added (g mL-1 ) 5.0 BCG 5.0 BBTBa5.0 10 15 five.0 10Enrocin 10 injectable Avitryl 20 injectable Total found (g mL-1 ) Recovery a SD Total identified (g mL-1 ) Recovery SD 9.92 99.20 0.48 9.94 99.40 0.46 14.94 99.60 0.66 15.20 100.ten 0.72 19.98 ten.05 14.91 19.84 99.90 0.82 one hundred.50 0.56 99.40 0.83 99.20 1.20 19.90 9.97 15.05 19.82 99.50.